<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ABBV
AbbVie
$
()


  • AbbVie price target raised by $10 at Barclays, here's why

    3/26/2024 - 20:24pm
  • Fly Insider: NextNav, Akamai among week's notable insider trades

    3/25/2024 - 14:44pm
  • AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR

    3/25/2024 - 08:35am
  • AbbVie to acquire Landos Biopharma got $20.42 per share in cash

    3/25/2024 - 08:34am
  • AbbVie to acquire Landos Biopharma for $20.42 per share in cash

    3/25/2024 - 08:32am
  • AbbVie confirms FDA grants full approval for Elahere for certain ovarian cancers

    3/22/2024 - 15:06pm
  • FDA approves mirvetuximab soravtansine-gynx for certain cancers

    3/22/2024 - 14:34pm
  • AbbVie price target raised by $2 at Guggenheim, here's why

    3/22/2024 - 06:42am
  • JPMorgan biotech/pharma analysts hold an analyst/industry conference call

    3/15/2024 - 12:03pm
  • Allergan Aesthetics announces FDA approval of JUVEDERM VOLUMA XC

    3/5/2024 - 08:08am
  • AbbVie makes milestone payment to Dragonfly after dosing in solid tumor trial

    3/5/2024 - 07:16am
  • AbbVie, OSE Immunotherapeutics enter pact to develop OSE-230

    2/28/2024 - 06:06am
  • Regenxbio expects cash to fund operations into 2H25

    2/27/2024 - 16:08pm
  • AbbVie's epcoritamab granted priority review by FDA in follicular lymphoma

    2/27/2024 - 07:49am
  • Genmab, AbbVie announce FDA priority review for sBLA

    2/27/2024 - 07:48am
dynamic_feed Breaking News